A Systematic Review of Human Trials Using Stem Cell Therapy for Erectile Dysfunction

Area of Science:

• Regenerative Medicine
• Urology
• Clinical Trials

Background:

• Erectile dysfunction (ED) is a condition with limited effective treatments.
• Stem cell therapy (SCT) offers a potential novel therapeutic approach for ED.
• While rodent studies exist, human data on SCT for ED is scarce.

Purpose of the Study:

• To systematically review human clinical trials on stem cell therapy (SCT) for erectile dysfunction (ED).
• To evaluate the safety and efficacy of SCT in treating ED based on available human studies.

Main Methods:

• Systematic review of human studies on SCT for ED.
• Literature search conducted on PubMed-Medline and Scopus databases.
• Adherence to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.

Main Results:

• Five phase I and II clinical trials involving 61 patients were included.
• The majority of studies reported improvements in erectile function, penile vascular flow, and patient-reported outcomes.
• No serious adverse events were reported across all included studies.

Conclusions:

• Current human clinical trials suggest SCT is a promising restorative therapy for ED.
• Limited data necessitates further investigation into the safety, efficacy, and standardization of SCT for ED.
• The expansion of SCT clinics for ED underscores the urgency for rigorous scientific validation.